Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESAT: Anesthesia Agents in OSA
NCT02717780Phase 4Completed
- Sponsor
- Lausanne University Hospital
- Start
- Feb 2016
- Primary completion
- Jun 2018
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil, desflurane, sponsored by Lausanne University Hospital. Started Feb 2016; status: completed.
02
Drugs
remifentanildesflurane
Beyond the preview
Go deeper on NCT02717780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02717780.